Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Birgitte K. Schmidt ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.3% 3.1% 4.7% 4.8% 4.2% 4.1% 16.1% 15.9%   Credit score (0-100)   56 56 44 44 47 49 11 12   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,924 2,035 2,228 2,185 2,012 1,876 0.0 0.0   EBITDA   259 314 216 332 507 389 0.0 0.0   EBIT   -50.0 -53.0 -209 206 380 267 0.0 0.0   Pre-tax profit (PTP)   -117.0 -119.0 -277.0 135.0 322.0 221.3 0.0 0.0   Net earnings   -117.0 -119.0 -277.0 135.0 322.0 221.3 0.0 0.0   Pre-tax profit without non-rec. items   -117 -119 -277 135 322 221 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   204 630 419 328 201 177 0.0 0.0   Shareholders equity total   -592 -711 -988 -853 -531 -310 -360 -360   Interest-bearing liabilities   797 953 743 376 136 0.0 360 360   Balance sheet total (assets)   825 981 647 568 493 370 0.0 0.0   Net Debt   726 938 732 367 44.0 -73.6 360 360     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,924 2,035 2,228 2,185 2,012 1,876 0.0 0.0   Gross profit growth   7.2% 5.8% 9.5% -1.9% -7.9% -6.8% -100.0% 0.0%   Employees   4 4 4 4 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   825 981 647 568 493 370 0 0   Balance sheet change%   -20.3% 18.9% -34.0% -12.2% -13.2% -24.9% -100.0% 0.0%   Added value   259.0 314.0 216.0 332.0 506.0 389.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -617 -155 -850 -217 -254 -147 -177 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2.6% -2.6% -9.4% 9.4% 18.9% 14.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -3.4% -3.4% -12.6% 13.5% 31.1% 31.3% 0.0% 0.0%   ROI %   -4.2% -4.3% -16.0% 24.4% 67.8% 40.2% 0.0% 0.0%   ROE %   -12.6% -13.2% -34.0% 22.2% 60.7% 51.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   -41.8% -42.0% -60.4% -60.0% -51.9% -45.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   280.3% 298.7% 338.9% 110.5% 8.7% -18.9% 0.0% 0.0%   Gearing %   -134.6% -134.0% -75.2% -44.1% -25.6% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.7% 7.5% 8.0% 12.7% 22.7% 67.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.5 0.2 0.3 0.4 0.7 2.0 0.0 0.0   Current Ratio   0.5 0.2 0.3 0.4 0.7 2.0 0.0 0.0   Cash and cash equivalent   71.0 15.0 11.0 9.0 92.0 73.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -234.0 -527.0 -486.0 -370.0 -123.0 97.4 -179.9 -179.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   65 79 54 83 169 130 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   65 79 54 83 169 130 0 0   EBIT / employee   -13 -13 -52 52 127 89 0 0   Net earnings / employee   -29 -30 -69 34 107 74 0 0